149 Reports in Pharmaceuticals
Antiemetics: Technologies and Global Markets
The global market for antiemetics reached $4.1 billion in 2017 and should reach $5.9 billion by 2022, at a compound annual growth rate (CAGR) of 6.5% during the forecast period of 2018-2023.
Pharmaceuticals for Women's Health: Global Markets to 2023
The global market for women’s health therapeutics reached nearly $30.5 billion in 2018 and should reach nearly $37.3 billion by 2023, at a compound annual growth rate (CAGR) of 4.2% for the period of 2018-2023.
Cognition and Memory Enhancement Drugs: Technologies and Global M...
The global cognition and memory-enhancing drugs market should reach over $4.2 billion by 2022 from $2.8 billion in 2017 at a compound annual growth rate (CAGR) of 8.7% for the period 2017-2022.
Active Pharmaceutical Ingredients: Global Markets to 2022
The global active pharmaceutical ingredient (API) market should reach $154.7 billion by 2022 from $114.2 billion in 2017 at a compound annual growth rate (CAGR) of 6.2% for the period 2017-2022.
Neuroprotective Agents: Therapeutic Applications and Global Marke...
The global market for neuroprotective agents will grow from $54.4 billion in 2017 to $75.8 billion by 2022 with a compound annual growth rate (CAGR) of 6.8% for the period of 2017-2022.
Antiulcerant Drugs: Global Markets to 2022
The global antiulcerant drugs market will grow from $33.0 billion in 2017 to $37.4 billion by 2022 with a compound annual growth rate (CAGR) of 2.5% for the period of 2017-2022.
Clinical Nutrition: Global Markets to 2022
The global clinical nutrition market should reach $60.8 billion by 2022 from $48.2 billion in 2017 at a compound annual growth rate (CAGR) of 4.8% for the period 2017-2022.
The Global Influenza Market
The global influenza market was valued at nearly $5.6 billion in 2017 and is expected to reach nearly $6.5 billion by 2022, increasing at a compound annual growth rate (CAGR) of 3.0% from 2017 through 2022.
Circulating Tumor Cell (CTC) Diagnostics: Technologies and Global...
The global market for circulating tumor cell technology will grow from nearly $4.6 billion in 2017 to around $10.3 billion by 2022 with a compound annual growth rate (CAGR) of 17.6% for the period of 2017-2022.
Excipients in Pharmaceuticals: Global Markets to 2022
The global market for pharmaceutical excipients will grow from nearly $6.8 billion in 2017 to $8.7 billion by 2022 with a compound annual growth rate (CAGR) of 4.9% for the period of 2017-2022.
Drugs for Urinary Incontinence and Overactive Bladder: Global Mar...
The global drugs for urinary incontinence and overactive bladder market should reach $4.2 billion by 2022 from $3.6 billion in 2017 at a compound annual growth rate (CAGR) of 2.9%, from 2017 to 2022.
Muscle Relaxants: Global Markets to 2022
The global muscle relaxants market totaled $18.4 billion in 2017 and is estimated to reach $24.4 billion by 2022, growing at a compound annual growth rate (CAGR) of 5.8% for the period of 2017-2022.
Anti-Epileptic Drugs: Global Markets to 2022
The global anti-epileptic drugs market totaled $8.4 billion in 2017 and is estimated to reach $9.5 billion by 2022, growing at a compound annual growth rate (CAGR) of 2.7% for the period of 2017-2022.
Drugs for Infertility: Global Markets to 2022
The global market for drugs for infertility should reach $4.2 billion by 2022 from $3.4 billion in 2017 at a compound annual growth rate (CAGR) of 4.3%, from 2017 to 2022.
Global Markets for Vaccine Technologies
The global market for vaccine technologies reached $35.7 billion in 2017 and should reach nearly $46.6 billion by 2022, at a compound annual growth rate (CAGR) of 5.5% for the period of 2017-2022.
Cardiovascular Drugs: Global Markets to 2022
The global cardiovascular drugs market should reach $149.4 billion by 2022 from $141.1 billion in 2017 at a compound annual growth rate (CAGR) of 1.2%, from 2017 to 2022.
Drugs for Rheumatoid Arthritis: Global Markets to 2022
The global rheumatoid arthritis drugs market totaled $1.7 billion in 2017 and is estimated to reach $2.3 billion by 2022, growing at a compound annual growth rate (CAGR) of 6.6% for the period of 2017-2022.
Global Markets for Contract Pharmaceutical Manufacturing, Researc...
The global market for pharmaceutical contract manufacturing, contract research and contract packaging will grow from $136.4 billion in 2017 to $197.0 billion by 2022 with a compound annual growth rate (CAGR) of 7.6% for the period of 2017-2022.
Anti-Parkinson's Drugs: Global Markets to 2022
The global anti-Parkinson’s drugs market should reach $5.7 billion by 2022 from $4.2 billion in 2017 at a compound annual growth rate (CAGR) of 6.1% from 2017 to 2022.
Global Markets for Infectious Disease Treatments
The global market for infectious disease treatments totaled $64.8 billion in 2017. The market should total $99 billion by 2022, growing at a compound annual growth rate (CAGR) of 8.9% from 2017 to 2022.
Global Cancer Therapeutics Market: Emphasis on Recurrent and Meta...
The global cancer therapeutics market should reach $172.6 billion by 2022 from $121 billion in 2017 at a compound annual growth rate (CAGR) of 7.4%, from 2017 to 2022.
Medication Adherence: Systems, Technologies and Global Markets
The global market for medication adherence reached $1.7 billion in 2016 and should reach nearly $4.0 billion by 2021 at a compound annual growth rate (CAGR) of 18.0% from 2016 through 2021.
Substance Abuse and Addiction Treatment, Global Markets to 2021
The global substance abuse and addiction treatment market reached $3.1 billion in 2016 and should reach nearly $4.4 billion in 2021, at a compound annual growth rate (CAGR) of 7.0%.
Antibody Drug Conjugates: Technologies and Global Markets
The global market for antibody drug conjugates was valued at $1.3 billion in 2016. The market should reach $4.2 billion by 2021, growing at a compound annual growth rate (CAGR) of 25.5% from 2016 to 2021.
The Chinese Market for Cancer Intervention
The Chinese cancer intervention market reached nearly $41.1 billion in 2016. This market should reach $46.7 billion in 2017 and $89.3 billion by 2022, at a compound annual growth rate (CAGR) of 13.8% through 2022.
Choose your License
13 Upcoming Reports in Pharmaceuticals
Global Markets for Treatment and Diagnosis of Sexually Transmitted Diseases
Report Includes
- An overview of the global market scenario for diagnosis and treatments of sexually transmitted diseases
- Country specific data and analysis for United States, Canada, Mexico, France, Germany, U.K., Spain, China, India, Japan, Middle East and Africa
- Market breakdown in value terms for regional and country level with details on test types, disease areas, and treatment by drug class etc.
- Key sectional assessments for major disease areas such as chlamydia, genital herpes, HIV, hepatitis, among others and a detailed analysis of epidemiology, historic and current disease incidence trends, therapeutic interventions, and diagnostic overview
- Discussion about market dynamics such as drivers, restraints, and trends along with regulatory scenario for United States, Europe, Japan and China to provide overview of the regulations for new drug launches and diagnostic kits
- Examination of competitive landscape and profiles of the major manufacturers involved in the sexually transmitted disease therapeutics market, key developments and their product offerings
